Dendritic cell immunoreceptor regulates Chikungunya virus pathogenesis in mice

Journal of Virology

Volumn 87, Issue 10, 2013, Pages 5697-5706

  Long, Kristin M ^a   Whitmore, Alan C ^a   Ferris, Martin T ^a   Sempowski, Gregory D ^b   McGee, Charles ^a   Trollinger, Bianca ^a   Gunn, Bronwyn ^a   Heisea, Mark T ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DENDRITIC CELL IMMUNORECEPTOR; LECTIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL COUNT; CELL SURFACE; CHIKUNGUNYA; CONTROLLED STUDY; CYTOKINE RESPONSE; DENDRITIC CELL; DISEASE SEVERITY; FOOT EDEMA; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY; VIRAL CLEARANCE; VIRUS REPLICATION; WEIGHT REDUCTION; WILD TYPE;

ALPHAVIRUS INFECTIONS; ANIMALS; ANKLE JOINT; CHIKUNGUNYA VIRUS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FOOT; HISTOCYTOCHEMISTRY; LECTINS, C-TYPE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84877327894     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01611-12     Document Type: Article

References (71)

1. Suhrbier A, La Linn M. 2004. Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr. Opin. Rheumatol. 16:374-379.
2. Harley D, Sleigh A, Ritchie S. 2001. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin. Microbiol. Rev. 14:909-932.
3. Williams MC, Woodall JP, Gillett JD. 1965. O'nyong-Nyong fever: an epidemic virus disease in East Africa. VII. Virus isolations from man and serological studies up to July 1961. Trans. R. Soc. Trop. Med. Hyg. 59: 186-197.
4. Robinson MC. 1955. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features. Trans. R. Soc. Trop. Med. Hyg. 49:28-32.
5. Lumsden WH. 1955. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology. Trans. R. Soc. Trop. Med. Hyg. 49:33-57.
6. Powers AM, Logue CH. 2007. Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus. J. Gen. Virol. 88:2363-2377.
7. Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel MP, Brehin AC, Cubito N, Despres P, Kunst F, Rey FA, Zeller H, Brisse S. 2006. Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med. 3:e263. doi:10.1371/journal.pmed.0030263.
8. Simon F, Tolou H, Jeandel P. 2006. The unexpected Chikungunya outbreak. Rev. Med. Interne 27:437-441. (In French.)
9. Sergon K, Njuguna C, Kalani R, Ofula V, Onyango C, Konongoi LS, Bedno S, Burke H, Dumilla AM, Konde J, Njenga MK, Sang R, Breiman RF. 2008. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am. J. Trop. Med. Hyg. 78:333-337.
10. Sergon K, Yahaya AA, Brown J, Bedja SA, Mlindasse M, Agata N, Allaranger Y, Ball MD, Powers AM, Ofula V, Onyango C, Konongoi LS, Sang R, Njenga MK, Breiman RF. 2007. Seroprevalence of Chikungunya virus infection on Grande Comore Island, Union of the Comoros, 2005. Am. J. Trop. Med. Hyg. 76:1189-1193.
11. Laras K, Sukri NC, Larasati RP, Bangs MJ, Kosim R, Djauzi Wandra T, Master J, Kosasih H, Hartati S, Beckett C, Sedyaningsih ER, Beecham HJ, III, Corwin AL. 2005. Tracking the re-emergence of epidemic Chikungunya virus in Indonesia. Trans. R. Soc. Trop. Med. Hyg. 99:128-141.
12. Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. 2007. Chikungunya, an epidemic arbovirosis. Lancet Infect. Dis. 7:319-327.
13. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A. 2007. Infection with Chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370:1840-1846.
14. Beltrame A, Angheben A, Bisoffi Z, Monteiro G, Marocco S, Calleri G, Lipani F, Gobbi F, Canta F, Castelli F, Gulletta M, Bigoni S, Del Punta V, Iacovazzi T, Romi R, Nicoletti L, Ciufolini MG, Rorato G, Negri C, Viale P. 2007. Imported Chikungunya infection, Italy. Emerg. Infect. Dis. 13:1264-1266.
15. Vazeille M, Jeannin C, Martin E, Schaffner F, Failloux AB. 2008. Chikungunya: a risk for Mediterranean countries? Acta Trop. 105:200-202.
16. Vazeille M, Moutailler S, Coudrier D, Rousseaux C, Khun H, Huerre M, Thiria J, Dehecq JS, Fontenille D, Schuffenecker I, Despres P, Failloux AB. 2007. Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS One 2:e1168. doi:10.1371/journal.pone .0001168.
17. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. 2007. A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 3:e201. doi:10.1371/journal.ppat.0030201.
18. Diallo M, Thonnon J, Traore-Lamizana M, Fontenille D. 1999. Vectors of Chikungunya virus in Senegal: current data and transmission cycles. Am. J. Trop. Med. Hyg. 60:281-286.
19. Simon F, Parola P, Grandadam M, Fourcade S, Oliver M, Brouqui P, Hance P, Kraemer P, Ali Mohamed A, de Lamballerie X, Charrel R, Tolou H. 2007. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine (Baltimore) 86:123-137.
20. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, Pierre V. 2009. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl. Trop. Dis. 3:e389. doi:10.1371/journal.pntd .0000389.
21. Mourya DT, Mishra AC. 2006. Chikungunya fever. Lancet 368:186-187.
22. Yazdani R, Kaushik VV. 2007. Chikungunya fever. Rheumatology (Oxford) 46:1214-1215.
23. Fourie ED, Morrison JG. 1979. Rheumatoid arthritic syndrome after Chikungunya fever. S Afr. Med. J. 56:130-132.
24. Kennedy AC, Fleming J, Solomon L. 1980. Chikungunya viral arthropathy: a clinical description. J. Rheumatol. 7:231-236.
25. Brighton SW, Simson IW. 1984. A destructive arthropathy following Chikungunya virus arthritis-a possible association. Clin. Rheumatol. 3:253-258.
26. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK, Sudeep AB, Muruganandam N, Chaitanya IK, Guruprasad DR. 2010. Clinical progression of Chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans. R. Soc. Trop. Med. Hyg. 104:392-399.
27. Soumahoro MK, Gerardin P, Boelle PY, Perrau J, Fianu A, Pouchot J, Malvy D, Flahault A, Favier F, Hanslik T. 2009. Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS One 4:e7800. doi:10.1371/journal.pone.0007800.
28. Kam YW, Ong EK, Renia L, Tong JC, Ng LF. 2009. Immuno-biology of Chikungunya and implications for disease intervention. Microbes Infect. 11:1186-1196.
29. Rulli NE, Rolph MS, Srikiatkhachorn A, Anantapreecha S, Guglielmotti A, Mahalingam S. 2011. Protection from arthritis and myositis in a mouse model of acute Chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J. Infect. Dis. 204:1026-1030.
30. Ng LF, Chow A, Sun YJ, Kwek DJ, Lim PL, Dimatatac F, Ng LC, Ooi EE, Choo KH, Her Z, Kourilsky P, Leo YS. 2009. IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS One 4:e4261. doi:10 .1371/journal.pone.0004261.
31. Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, Tallet F, Moiton MP, Gauzere BA, Bruniquet S, Jaffar Bandjee Z, Morbidelli P, Martigny G, Jolivet M, Gay F, Grandadam M, Tolou H, Vieillard V, Debre P, Autran B, Gasque P. 2010. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol. 184:5914-5927.
32. Chow A, Her Z, Ong EK, Chen JM, Dimatatac F, Kwek DJ, Barkham T, Yang H, Renia L, Leo YS, Ng LF. 2011. Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J. Infect. Dis. 203:149-157.
33. Lidbury BA, Rulli NE, Suhrbier A, Smith PN, McColl SR, Cunningham AL, Tarkowski A, van Rooijen N, Fraser RJ, Mahalingam S. 2008. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J. Infect. Dis. 197:1585-1593.
34. Morrison TE, Whitmore AC, Shabman RS, Lidbury BA, Mahalingam S, Heise MT. 2006. Characterization of Ross River virus tropism and virusinduced inflammation in a mouse model of viral arthritis and myositis. J. Virol. 80:737-749.
35. Lidbury BA, Simeonovic C, Maxwell GE, Marshall ID, Hapel AJ. 2000. Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J. Infect. Dis. 181:27-34.
36. Gunn BM, Morrison TE, Whitmore AC, Blevins LK, Hueston L, Fraser RJ, Herrero LJ, Ramirez R, Smith PN, Mahalingam S, Heise MT. 2012. Mannose binding lectin is required for alphavirus-induced arthritis/ myositis. PLoS Pathog. 8:e1002586. doi:10.1371/journal.ppat.1002586.
37. Shabman RS, Morrison TE, Moore C, White L, Suthar MS, Hueston L, Rulli N, Lidbury B, Ting JP, Mahalingam S, Heise MT. 2007. Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J. Virol. 81:237-247.
38. Shabman RS, Rogers KM, Heise MT. 2008. Ross River virus envelope glycans contribute to type I interferon production in myeloid dendritic cells. J. Virol. 82:12374-12383.
39. Klimstra WB, Nangle EM, Smith MS, Yurochko AD, Ryman KD. 2003. DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell-and mammalian cell-derived viruses. J. Virol. 77:12022-12032.
40. Ryman KD, Klimstra WB. 2008. Host responses to alphavirus infection. Immunol. Rev. 225:27-45.
41. Knight RL, Schultz KL, Kent RJ, Venkatesan M, Griffin DE. 2009. Role of N-linked glycosylation for Sindbis virus infection and replication in vertebrate and invertebrate systems. J. Virol. 83:5640-5647.
42. Bates EE, Fournier N, Garcia E, Valladeau J, Durand I, Pin JJ, Zurawski SM, Patel S, Abrams JS, Lebecque S, Garrone P, Saeland S. 1999. APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J. Immunol. 163:1973-1983.
43. Richard M, Thibault N, Veilleux P, Breton R, Beaulieu AD. 2003. The ITIM-bearing CLECSF6 (DCIR) is down-modulated in neutrophils by neutrophil activating agents. Biochem. Biophys. Res. Commun. 310:767-773.
44. Fujikado N, Saijo S, Yonezawa T, Shimamori K, Ishii A, Sugai S, Kotaki H, Sudo K, Nose M, Iwakura Y. 2008. DCIR deficiency causes development of autoimmune diseases in mice due to excess expansion of dendritic cells. Nat. Med. 14:176-180.
45. Kanazawa N, Okazaki T, Nishimura H, Tashiro K, Inaba K, Miyachi Y. 2002. DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif. J. Invest. Dermatol. 118:261-266.
46. Eklow C, Makrygiannakis D, Backdahl L, Padyukov L, Ulfgren AK, Lorentzen JC, Malmstrom V. 2008. Cellular distribution of the C-type II lectin dendritic cell immunoreceptor (DCIR) and its expression in the rheumatic joint: identification of a subpopulation of DCIRT cells. Ann. Rheum. Dis. 67:1742-1749.
47. Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, Elmore SA, Heise MT. 2011. A mouse model of Chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am. J. Pathol. 178:32-40.
48. Hamer PW, McGeachie JM, Davies MJ, Grounds MD. 2002. Evans blue dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability. J. Anat. 200:69-79.
49. Serody JS, Collins EJ, Tisch RM, Kuhns JJ, Frelinger JA. 2000. T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery. J. Immunol. 164:4961-4967.
50. White LJ, Wang JG, Davis NL, Johnston RE. 2001. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5′ untranslated region. J. Virol. 75:3706-3718.
51. Team RDC. 2010. R: a language and environment for statistical computing. Team RDC, Vienna, Austria.
52. Gardner J, Anraku I, Le TT, Larcher T, Major L, Roques P, Schroder WA, Higgs S, Suhrbier A. 2010. Chikungunya virus arthritis in adult wild-type mice. J. Virol.
53. Meyer-Wentrup F, Cambi A, Joosten B, Looman MW, de Vries IJ, Figdor CG, Adema GJ. 2009. DCIR is endocytosed into human dendritic cells and inhibits TLR8-mediated cytokine production. J. Leukoc. Biol. 85:518-525.
54. Meyer-Wentrup F, Benitez-Ribas D, Tacken PJ, Punt CJ, Figdor CG, de Vries IJ, Adema GJ. 2008. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 111:4245-4253.
55. Lambert AA, Gilbert C, Richard M, Beaulieu AD, Tremblay MJ. 2008. The C-type lectin surface receptor DCIR acts as a new attachment factor for HIV-1 in dendritic cells and contributes to trans-and cis-infection pathways. Blood 112:1299-1307.
56. Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML. 2010. Type I IFN controls Chikungunya virus via its action on nonhematopoietic cells. J. Exp. Med. 207:429-442.
57. Plante K, Wang E, Partidos CD, Weger J, Gorchakov R, Tsetsarkin K, Borland EM, Powers AM, Seymour R, Stinchcomb DT, Osorio JE, Frolov I, Weaver SC. 2011. Novel Chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism. PLoS Pathog. 7:e1002142. doi:10.1371/journal.ppat.1002142.
58. Wolman M, Klatzo I, Chui E, Wilmes F, Nishimoto K, Fujiwara K, Spatz M. 1981. Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol. 54:55-61.
59. Matsuda R, Nishikawa A, Tanaka H. 1995. Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J. Biochem. 118:959-964.
60. Schilte C, Buckwalter MR, Laird ME, Diamond MS, Schwartz O, Albert ML. 2012. Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection. J. Immunol. 188:2967-2971.
61. Clavarino G, Claudio N, Couderc T, Dalet A, Judith D, Camosseto V, Schmidt EK, Wenger T, Lecuit M, Gatti E, Pierre P. 2012. Induction of GADD34 is necessary for dsRNA-dependent interferon-beta production and participates in the control of Chikungunya virus infection. PLoS Pathog. 8:e1002708. doi:10.1371/journal.ppat.1002708.
62. Lorentzen JC, Flornes L, Eklow C, Backdahl L, Ribbhammar U, Guo JP, Smolnikova M, Dissen E, Seddighzadeh M, Brookes AJ, Alfredsson L, Klareskog L, Padyukov L, Fossum S. 2007. Association of arthritis with a gene complex encoding C-type lectin-like receptors. Arthritis Rheum. 56: 2620-2632.
63. Chen ST, Lin YL, Huang MT, Wu MF, Cheng SC, Lei HY, Lee CK, Chiou TW, Wong CH, Hsieh SL. 2008. CLEC5A is critical for denguevirus-induced lethal disease. Nature 453:672-676.
64. Chen ST, Liu RS, Wu MF, Lin YL, Chen SY, Tan DT, Chou TY, Tsai IS, Li L, Hsieh SL. 2012. CLEC5A regulates Japanese encephalitis virusinduced neuroinflammation and lethality. PLoS Pathog. 8:e1002655. doi: 10.1371/journal.ppat.1002655.
65. Ramful D, Carbonnier M, Pasquet M, Bouhmani B, Ghazouani J, Noormahomed T, Beullier G, Attali T, Samperiz S, Fourmaintraux A, Alessandri JL. 2007. Mother-to-child transmission of Chikungunya virus infection. Pediatr. Infect. Dis. J. 26:811-815.
66. Guo J, Wu X, Too CL, Yin F, Lu X, He J, Li R, Liu X, Murad S, Padyukov L, Li Z. 2012. A replication study confirms the association of dendritic cell immunoreceptor (DCIR) polymorphisms with ACPAnegative RA in a large Asian cohort. PLoS One 7:e41228. doi:10.1371 /journal.pone.0041228.
67. Ronninger M, Eklow C, Lorentzen JC, Klareskog L, Padyukov L. 2008. Differential expression of transcripts for the autoimmunity-related human dendritic cell immunoreceptor. Genes Immun. 9:412-418.
68. Huang X, Yuan Z, Chen G, Zhang M, Zhang W, Yu Y, Cao X. 2001. Cloning and characterization of a novel ITIM containing lectin-like immunoreceptor LLIR and its two transmembrane region deletion variants. Biochem. Biophys. Res. Commun. 281:131-140.
69. Lambert AA, Barabe F, Gilbert C, Tremblay MJ. 2011. DCIR-mediated enhancement of HIV-1 infection requires the ITIM-associated signal transduction pathway. Blood 117:6589-6599.
70. Kanazawa N, Tashiro K, Miyachi Y. 2004. Signaling and immune regulatory role of the dendritic cell immunoreceptor (DCIR) family lectins: DCIR, DCAR, dectin-2 and BDCA-2. Immunobiology 209:179-190.
71. Mann HB, Whitney DR. 1947. On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Stat. 18:50-60.